Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.36%
1,040.69
-3.71
-0.36%
—1,044.401,041.751,048.311,037.77——
SIXC
Communications
SIXC
Communications
SIXC
-1.59%
560.36
-9.05
-1.59%
—569.41569.41569.41558.54——
SIXE
Energy
SIXE
Energy
SIXE
+1.71%
1,317.69
+22.18
+1.71%
—1,295.511,294.951,321.871,289.74——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.27%
1,606.91
-20.60
-1.27%
—1,627.511,623.211,627.281,603.21——
SIXM
Financials
SIXM
Financials
SIXM
-2.49%
590.28
-15.10
-2.49%
—605.38603.79603.79588.51——
SIXR
Staples
SIXR
Staples
SIXR
+0.79%
827.98
+6.50
+0.79%
—821.48822.07833.11819.99——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.68%
197.04
-1.35
-0.68%
—198.39198.39199.10196.67——
SIXT
Technology
SIXT
Technology
SIXT
-1.92%
2,618.20
-51.38
-1.92%
—2,669.582,654.812,660.502,611.26——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.61%
924.66
+5.61
+0.61%
—919.05920.79933.78918.70——
SIXV
Health care
SIXV
Health care
SIXV
-1.71%
1,449.59
-25.17
-1.71%
—1,474.761,475.771,475.771,447.42——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-2.87%
2,136.89
-63.11
-2.87%
—2,200.002,191.332,191.332,132.17——
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.20
-0.04%
(-0.000080) 1D
$0.21
+0.48% (+0.00098)
After hours
Closed: Mar 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
$0.20
High
$0.21
Low
$0.20
Mkt. cap
305.80M
Avg. vol.
2.26M
Volume
2.05M
52-wk high
$0.48
52-wk low
$0.17
EPS
-$0.07
Beta
-0.81
Shares outstanding
1.54B
No. of employees
25
News stories
From sources across the web
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees25
FoundedJan 1, 1998
Headquarters-
SectorBiotechnology
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
231.00K
375.00K
131.00K
200.00K
Cost of goods sold
10.52M
8.35M
7.43M
7.45M
Cost of revenue
10.52M
8.35M
7.43M
7.45M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.21M
9.34M
7.48M
7.07M
Operating expense
8.21M
9.34M
7.48M
7.07M
Total operating expenses
18.73M
17.69M
14.91M
14.52M
Operating income
-18.50M
-17.31M
-14.78M
-14.32M
Other non operating income
-1.41M
1.26M
484.00K
-3.45M
EBT including unusual items
-28.22M
-19.34M
-15.38M
-26.83M
EBT excluding unusual items
-25.99M
-15.76M
-12.48M
-21.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.22M
-19.34M
-15.38M
-26.83M
Net profit margin
-12,217.75%
-5,158.13%
-11,738.93%
-13,414.50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.49M
-1.60M
-1.83M
-2.62M
Net interest expenses
-2.49M
-1.60M
-1.83M
-2.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.06M
-16.88M
-14.33M
-13.87M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer